Vanguard Group Inc Lucid Diagnostics Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 560,915 shares of LUCD stock, worth $426,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
560,915
Previous 560,915
-0.0%
Holding current value
$426,295
Previous $459,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LUCD
# of Institutions
31Shares Held
2.54MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.15MShares$876,2150.56% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$162,2900.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$96,0350.01% of portfolio
-
Lido Advisors, LLC Los Angeles, CA100KShares$76,0120.0% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$56,1693.26% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $29.3M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...